Dr. Hanns Lochmüller Receives the Dr. George Karpati Award for Researcher of the Year

Dr. Hanns Lochmüller is the recipient of Muscular Dystrophy Canada‘s Dr. George Karpati Award for Researcher of the Year! This prestigious award is presented annually to an exemplary neuromuscular clinician or researcher who has made a significant contribution to neuromuscular research, or the advancement of care of people with neuromuscular disorders. 

Dr. Lochmuller is a neurologist and clinical academic specializing in genetic neuromuscular disorders and rare disease in Ottawa, and supports the neuromuscular community in many ways: He is the lead Principal Investigator of the Neuromuscular Disease Network for Canada (NMD4C); He is an active member of MDC’s Medical and Scientific Advisory Committee (MSAC); He reviews research grants, speaks at various webinars, contributes to publications (over 30 in 2021 alone!), serves as a role model for early career clinicians and scientists, as well as serving as an academic lead on MDC’s Economic Cost of Living Study.

Dr. Lochmuller is a champion for the patient community and is strongly committed to bringing patients and patient organizations into equal partnerships. He has been instrumental in ensuring individuals impacted by NMDs and their family members are at the center of advances in the neuromuscular community in Canada and abroad.

Read more about Dr. Lochmüller’s accomplishments and research here.

Hanns_KarpatiAward_MDClogo

Read next...

researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...
award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...